Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men

被引:17
作者
Agalliu, Ilir
Weiss, Noel S.
Lin, Daniel W.
Stanford, Janet L.
机构
[1] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA
[2] Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA
[3] Univ Washington, Med Ctr, Dept Urol, Seattle, WA USA
关键词
prostate cancer screening; prostate-specific antigen (PSA) test; digital rectal examination; prostate cancer-specific mortality;
D O I
10.1007/s10552-007-9031-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Although prostate cancer screening by measurement of serum prostate-specific antigen (PSA) and digital rectal examination (DRE) is common in clinical practice, the impact of such screening on prostate cancer-specific mortality remains uncertain. Methods Data from a population-based case-control study in King County, Washington, among men aged 50-64 years (706 cases, 645 controls) were used to examine the relationships between PSA and DRE screening and fatal prostate cancer and other-cause mortality. Incident cases were diagnosed in 1993-1996, identified via the Seattle-Puget Sound SEER cancer registry and followed for vital status through 1 June 2007. Controls were ascertained by random digit dialing and frequency age-matched to cases. The screening variable used in this analysis was self-reported receipt of one or more PSA and/or DRE tests performed as part of a routine checkup in the five-year period before diagnosis or reference date. Results A smaller proportion of men with fatal prostate cancer had one or more PSA and/or DRE screening tests compared to controls, resulting in an adjusted odds ratios (OR) of 0.38 (95% CI 0.19-0.77). There was no association, however, between PSA and/or DRE screening and other-cause mortality (OR = 1.02; 95% CI 0.51-2.02). Conclusions Results of this study suggest a reduction in prostate cancer-specific mortality associated with PSA and/or DRE screening in middle-aged men. Findings should be interpreted cautiously, however, as results are based on observational data. Further, the study was not able to separate the relative efficacy of PSA versus DRE screening.
引用
收藏
页码:931 / 937
页数:7
相关论文
共 50 条
[41]   Prostate-specific antigen levels of ≤4 and >4 ng/mL and risk of prostate cancer-specific mortality in men with biopsy Gleason score 9 to 10 prostate cancer [J].
Kim, Daniel W. ;
Chen, Ming-Hui ;
Wu, Jing ;
Huland, Hartwig ;
Graefen, Markus ;
Tilki, Derya ;
D'Amico, Anthony, V .
CANCER, 2021, 127 (13) :2222-2228
[42]   Are magnetic resonance imaging and targeted biopsies needed in men with serum prostate-specific antigen over 10 ng/ml and an abnormal digital rectal examination? [J].
Morote, Juan ;
Picola, Natalia ;
Paesano, Nahuel ;
Celma, Anna ;
Munoz-Rodriguez, Jesus ;
Asiain, Ignacio ;
Ruiz-Plazas, Xavier ;
Munoz-Rivreo, Marta, V ;
de Manuel, Gemma Garcia ;
Servian, Pol ;
Abascal, Jose M. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (07) :299-301
[43]   Urinary prostate-specific antigen and microseminoprotein-beta levels in men with and without prostate cancer: A prospective cohort study [J].
Shrivastava, Prashant ;
Garg, Harshit ;
Bhat, Madhusudan ;
Dinda, Amit ;
Kumar, Rajeev .
INDIAN JOURNAL OF UROLOGY, 2020, 36 (01) :50-55
[44]   Prostate-specific antigen recurrence and mortality after conventional dose radiation therapy in select men with low-risk prostate cancer [J].
Petit, Joshua H. ;
Chen, Ming-Hui ;
Loffredo, Marian ;
Sussman, Brenda ;
Renshaw, Andrew A. ;
D'Amico, Anthony V. .
CANCER, 2006, 107 (09) :2180-2185
[45]   IS TRANSRECTAL ULTRASONOGRAPHY NEEDED TO RULE OUT PROSTATIC-CANCER WITH NORMAL FINDINGS AT DIGITAL RECTAL EXAMINATION AND NORMAL SERUM PROSTATE-SPECIFIC ANTIGEN [J].
SIMAK, R ;
EISENMENGER, M ;
HAINZ, A ;
KRATZIK, C ;
MARBERGER, M .
EUROPEAN UROLOGY, 1993, 24 (04) :474-478
[46]   Characteristics of Prostate Cancer by Opportunistic Screening in Korean Men with a Prostate-Specific Antigen Level Less Than 4.0 ng per Milliliter [J].
Choi, Hoon ;
Cho, Seok ;
Bae, Jae Hyun ;
Lee, Sang Eun ;
Hong, Sung Kyu ;
Moon, Du Geon ;
Cheon, Jun ;
Byun, Seok-Soo ;
Park, Jae Young .
UROLOGIA INTERNATIONALIS, 2017, 99 (02) :143-148
[47]   Digital Rectal Examination in Stockholm3 Biomarker-based Prostate Cancer Screening [J].
Andersson, Joel ;
Palsdottir, Thorgerdur ;
Lantz, Anna ;
Aly, Markus ;
Gronberg, Henrik ;
Egevad, Lars ;
Eklund, Martin ;
Nordstrom, Tobias .
EUROPEAN UROLOGY OPEN SCIENCE, 2022, 44 :69-75
[48]   Implementation of a 5-Minute Magnetic Resonance Imaging Screening Protocol for Prostate Cancer in Men With Elevated Prostate-Specific Antigen Before Biopsy [J].
Weiss, Jakob ;
Martirosian, Petros ;
Notohamiprodjo, Mike ;
Kaufmann, Sascha ;
Othman, Ahmed E. ;
Grosse, Ulrich ;
Nikolaou, Konstantin ;
Gatidis, Sergios .
INVESTIGATIVE RADIOLOGY, 2018, 53 (03) :186-190
[49]   An abnormal digital rectal examination is an independent predictor of Gleason ≥7 prostate cancer in men undergoing initial prostate biopsy:: a prospective study of 790 men [J].
Borden, Lester S., Jr. ;
Wright, Jonathan L. ;
Kim, Jason ;
Latchamsetty, Kalyan ;
Porter, Christopher R. .
BJU INTERNATIONAL, 2007, 99 (03) :559-563
[50]   Digital Rectal Examination and the Diagnosis of Prostate Cancer-a Study Based on 8 Years and Three Screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam [J].
Gosselaar, Claartje ;
Roobol, Monique J. ;
van den Bergh, Roderick C. N. ;
Wolters, Tineke ;
Schroder, Fritz H. .
EUROPEAN UROLOGY, 2009, 55 (01) :139-147